Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH plus GnRH agonist for pubertal children with idiopathic short stature
2007-003247-70Phase 3Completed
- Sponsor
- Belgian Study Group for Pediatric Endocrinology
- Start
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label trial of somatropin and triptorelin in Idiopathic Short Stature (ISS) (2 arms), sponsored by Belgian Study Group for Pediatric Endocrinology. Primary endpoint: Final height. Started Oct 2007; status: completed.
02
Drugs
somatropintriptorelin
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on 2007-003247-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003247-70.